Skip to content
  • About us
    • Advisory Board
    • Our mission
    • GDPR Policy
  • Editorial guidelines
    • Peer-review protocol
    • Author guidelines
    • Editorial Calendar 2018
    • Editorial Calendar 2017
  • Advertise with us
    • Media Information 2021
    • Media Information 2020
  • Subscribe
    • weekly newsletter
  • Contact Us
secondary menu
Journal for Clinical Studies
Journal for Clinical StudiesJournal for Clinical Studies
 

 

  • Home
  • Current features/ Volume 13 Issue 1
  • Editorial Archive
    • Volume 12 Issue 6
    • Volume 12 Issue 5
    • Volume 12 Issue 4
    • Volume 12 Issue 3
    • Volume 12 Issue 2
    • Volume 12 Issue 1
    • Volume 11 Issue 6
    • Volume 11 Issue 5
    • Volume 11 Issue 4
    • Volume 11 Issue 3
    • Volume 11 Issue 2
    • Volume 11 Issue 1
    • Volume 10 Issue 6
    • Volume 10 Issue 5
    • Volume 10 Issue 4
    • Volume 10 Issue 3
    • Volume 10 Issue 2
    • Volume 10 Issue 1
    • Volume 9 Issue 6
      • Volume 10 Issue 6
    • Volume 9 Issue 5
    • Volume 9 Issue 4
    • Volume 9 Issue 3
    • Volume 9 Issue 2
    • Volume 9 Issue 1
      • Regulatory V9 I1
      • Market Report V9 I1
      • Therapeutics V9 I1
      • IT & Logistics V9 I1
    • Volume 8 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Technology
      • Therapeutics
      • Special Features
      • Logistics
    • Volume 8 Issue 5
      • Watch Pages V8 I5
      • Regulatory V8 I5
      • Market Report V8 I5
      • Technology V8 I5
      • Therapeutics V8 I5
      • Special Features V8 I5
      • Logistics V8 I5
    • Volume 8 Issue 4
      • Watch Pages V8 I4
      • Regulatory V8 I4
      • Market Report V8 I4
      • Therapeutics V8 I4
      • Technology V8 I4
      • Logistics V8 I4
      • Special Feature V8 I4
    • Volume 8 Issue 3
      • Watch Pages V8 I3
      • Regulatory V8 I3
      • Market Report V8 I3
      • Therapeutics V8 I3
      • Technology V8 I3
      • Logistics V8 I3
      • Special Feature V8 I3
    • Volume 8 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 8 Issue 1
    • Volumen 8 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 issue 3
      • Watch Pages
      • Therapeutics
      • Research & Development
      • Regulatory & Marketplace
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • Technology
      • Logistics
    • Volume 7 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • Technology
      • Logistics
    • Volume 6 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 3
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • It & Logistics
      • Special Features
    • Volume 6 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 5 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • It & Logistics
      • Therapeutics
      • Special Features
    • Volume 5 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 5 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Feature
    • Volume 5 Issue 3
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
  • Archived Issues
  • Industry events
  • Company Profile
    • A-D
    • E-M
    • N-S
    • T-Z
  • Regional News
    • Asia Pacific
    • Australasia
    • Europe
    • Latin America
    • MEANA Region
    • North America
    • Russia/Eastern Europe
    • Scandinavia
    • South Africa
    • Sub Saharan Africa
  • eBooks
  • Podcast
  • Home
  • Current features/ Volume 13 Issue 1
  • Editorial Archive
    • Volume 12 Issue 6
    • Volume 12 Issue 5
    • Volume 12 Issue 4
    • Volume 12 Issue 3
    • Volume 12 Issue 2
    • Volume 12 Issue 1
    • Volume 11 Issue 6
    • Volume 11 Issue 5
    • Volume 11 Issue 4
    • Volume 11 Issue 3
    • Volume 11 Issue 2
    • Volume 11 Issue 1
    • Volume 10 Issue 6
    • Volume 10 Issue 5
    • Volume 10 Issue 4
    • Volume 10 Issue 3
    • Volume 10 Issue 2
    • Volume 10 Issue 1
    • Volume 9 Issue 6
      • Volume 10 Issue 6
    • Volume 9 Issue 5
    • Volume 9 Issue 4
    • Volume 9 Issue 3
    • Volume 9 Issue 2
    • Volume 9 Issue 1
      • Regulatory V9 I1
      • Market Report V9 I1
      • Therapeutics V9 I1
      • IT & Logistics V9 I1
    • Volume 8 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Technology
      • Therapeutics
      • Special Features
      • Logistics
    • Volume 8 Issue 5
      • Watch Pages V8 I5
      • Regulatory V8 I5
      • Market Report V8 I5
      • Technology V8 I5
      • Therapeutics V8 I5
      • Special Features V8 I5
      • Logistics V8 I5
    • Volume 8 Issue 4
      • Watch Pages V8 I4
      • Regulatory V8 I4
      • Market Report V8 I4
      • Therapeutics V8 I4
      • Technology V8 I4
      • Logistics V8 I4
      • Special Feature V8 I4
    • Volume 8 Issue 3
      • Watch Pages V8 I3
      • Regulatory V8 I3
      • Market Report V8 I3
      • Therapeutics V8 I3
      • Technology V8 I3
      • Logistics V8 I3
      • Special Feature V8 I3
    • Volume 8 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 8 Issue 1
    • Volumen 8 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 7 issue 3
      • Watch Pages
      • Therapeutics
      • Research & Development
      • Regulatory & Marketplace
      • IT & Logistics
      • Special Features
    • Volume 7 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • Technology
      • Logistics
    • Volume 7 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • Technology
      • Logistics
    • Volume 6 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 3
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 6 Issue 2
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • It & Logistics
      • Special Features
    • Volume 6 Issue 1
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
    • Volume 5 Issue 6
      • Watch Pages
      • Regulatory
      • Market Report
      • It & Logistics
      • Therapeutics
      • Special Features
    • Volume 5 Issue 5
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Features
    • Volume 5 Issue 4
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
      • Special Feature
    • Volume 5 Issue 3
      • Watch Pages
      • Regulatory
      • Market Report
      • Therapeutics
      • IT & Logistics
  • Archived Issues
  • Industry events
  • Company Profile
    • A-D
    • E-M
    • N-S
    • T-Z
  • Regional News
    • Asia Pacific
    • Australasia
    • Europe
    • Latin America
    • MEANA Region
    • North America
    • Russia/Eastern Europe
    • Scandinavia
    • South Africa
    • Sub Saharan Africa
  • eBooks
  • Podcast

Tag Archives: drug

PROSTATE CANCER DRUG BYPRODUCT CAN FUEL CANCER CELLS, UNITED STATES-BASED RESEARCHERS FIND

Europe, North AmericaBy flabio518th July 2018

A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the…

Speeding Drug Development with Clinical Trials in a Dish

EuropeBy flabio56th June 2018

The average time to bring a new drug to market is 12 years—assuming it makes it through the rigorous regulatory…

AstraZeneca won’t submit lung drug for COPD after 2nd study miss

EuropeBy flabio56th June 2018

AstraZeneca no longer plans to seek approval of its new respiratory biologic Fasenra in chronic obstructive pulmonary disease (COPD) after the…

Redx Pharma up as it confirms cancer drug clinical trial will re-start early next year

EuropeBy flabio531st May 2018

After discussions with the regulator, RXC004 will be administered at a lower initial dose Redx Pharma plc(LON:REDX) shares gained on Wednesday…

India’s drug regulator expects to finalize new clinical trial rules in two months

Asia Pacific, EuropeBy flabio531st May 2018

India’s drug regulator plans to finalize new rules for clinical trials in a couple of months that would shorten the…

Bionomics begins phase II clinical trial of drug for treating agitation

Australasia, EuropeBy flabio523rd May 2018

Bionomics will recruit about 40 elderly patients in specialist geriatric hospital wards across Australia. Bionomics Ltd (ASX:BNO) has commenced a…

Virtual drug trials boost results

EuropeBy flabio52nd May 2018

Bringing drug trials to the virtual realm, Belinda Tan ’96 has found a way to cut entire process in half.…

Singapore, with strict drug laws, to develop synthetic marijuana compounds

Asia Pacific, EuropeBy flabio52nd May 2018

Singapore is funding research on medical treatments containing synthetically-derived compounds of the marijuana plant Singapore, known for some of the…

High Point Company’s Alzheimer’s Drug Trial Fails

Europe, UncategorizedBy flabio511th April 2018

The drug was in development for close to two decades. Experts say that without new drugs, Alzheimer’s efforts will need…

Janssen to begin phase 2 clinical trials of Hanmi Pharma’s diabetes drug

Asia Pacific, EuropeBy flabio54th April 2018

US pharmaceutical company Janssen will start carrying out phase 2 clinical trials in the US to evaluate the efficacy and…

12
© 2020 Jforcs Media, All Rights Reserved. Powered by Teksyte LTD
Go to Top